Griffith Law School, Griffith University, Parklands Queensland 4222.
CSIRO Synthetic Biology Future Science Research Fellow, Law Futures Centre, Griffith Law School, Griffith University, Nathan Queensland 4111.
J Law Med. 2022 Aug;29(3):663-676.
The World Trade Organization's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) provides for global minimum standard patents. These patents potentially limit access to products and processes for the surveillance, tracking, diagnosis and treatment of COVID-19. A possible solution currently under consideration is a TRIPS waiver of the implementation, application and enforcement for the prevention, containment or treatment of COVID-19. This article addresses the ways that TRIPS patents might be mediated including through TRIPS flexibilities. The article argues that there are sufficient means of derogating from patents (and potentially copyright, industrial designs and undisclosed information), although they alone will not resolve the access problems. The article concludes that the key patent problem is the transfer of know-how and that developing new ideas about addressing these patent know-how transfers is the presently unaddressed challenge.
世界贸易组织的《与贸易有关的知识产权协定》（TRIPS）规定了全球最低标准专利。这些专利可能会限制获取用于 COVID-19 监测、跟踪、诊断和治疗的产品和流程。目前正在考虑的一个可能的解决方案是 TRIPS 豁免，用于预防、控制或治疗 COVID-19。本文探讨了通过 TRIPS 灵活性来调解专利的方式。本文认为，虽然不足以解决获取问题，但已经有足够的方法来减损专利（以及可能的版权、工业设计和未公开信息）。本文结论认为，关键的专利问题是技术诀窍的转让，而提出解决这些专利技术诀窍转让的新想法是目前尚未解决的挑战。
